123 related articles for article (PubMed ID: 21420936)
1. 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells.
Geldmeyer-Hilt K; Heine G; Hartmann B; Baumgrass R; Radbruch A; Worm M
Biochem Biophys Res Commun; 2011 Apr; 407(4):699-702. PubMed ID: 21420936
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.
D'Ambrosio D; Cippitelli M; Cocciolo MG; Mazzeo D; Di Lucia P; Lang R; Sinigaglia F; Panina-Bordignon P
J Clin Invest; 1998 Jan; 101(1):252-62. PubMed ID: 9421488
[TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro.
Heine G; Anton K; Henz BM; Worm M
Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570
[TBL] [Abstract][Full Text] [Related]
4. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
Tse AK; Wan CK; Shen XL; Zhu GY; Cheung HY; Yang M; Fong WF
Exp Cell Res; 2007 May; 313(8):1722-34. PubMed ID: 17397830
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
[TBL] [Abstract][Full Text] [Related]
9. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.
El Mjiyad N; Bontems S; Gloire G; Horion J; Vandevenne P; Dejardin E; Piette J; Sadzot-Delvaux C
J Virol; 2007 Dec; 81(23):13092-104. PubMed ID: 17855547
[TBL] [Abstract][Full Text] [Related]
11. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
13. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells.
Liu S; Shi X; Bauer I; Günther J; Seyfert HM
Mol Immunol; 2011 Mar; 48(6-7):895-908. PubMed ID: 21255844
[TBL] [Abstract][Full Text] [Related]
14. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
15. Anti-sense morpholino oligonucleotide assay shows critical involvement for NF-kappaB activation in the production of Wnt-1 protein by HepG2 cells: oncology implications.
Sun CS; Wu KT; Lee HH; Uen YH; Tian YF; Tzeng CC; Wang AH; Cheng CJ; Tsai SL
J Biomed Sci; 2008 Sep; 15(5):633-43. PubMed ID: 18461473
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression.
Harant H; Andrew PJ; Reddy GS; Foglar E; Lindley IJ
Eur J Biochem; 1997 Nov; 250(1):63-71. PubMed ID: 9431991
[TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
18. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1.
Martin T; Cardarelli PM; Parry GC; Felts KA; Cobb RR
Eur J Immunol; 1997 May; 27(5):1091-7. PubMed ID: 9174597
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
Chang PY; Miyamoto S
Mol Cancer Res; 2006 Feb; 4(2):101-12. PubMed ID: 16513841
[TBL] [Abstract][Full Text] [Related]
20. Negative transcriptional regulation of human colonic smooth muscle Cav1.2 channels by p50 and p65 subunits of nuclear factor-kappaB.
Shi XZ; Pazdrak K; Saada N; Dai B; Palade P; Sarna SK
Gastroenterology; 2005 Nov; 129(5):1518-32. PubMed ID: 16285952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
